Why Private Equity Is Buying Up Hearing Aid Dispensaries

from The Buyout Show with Fexingo: Private Equity, Roll-Ups, and Business Acquisitions · host Fexingo

Lucas and Luna dive into a surprising roll-up target: hearing aid dispensaries. With the OTC hearing aid rule from 2022 finally reshaping the market, private equity sees a fragmented $8 billion industry ripe for consolidation. They break down how firms like Audibel and HearingLife are being acquired by larger platforms, the demographics driving demand, and why the average cost of a pair of hearing aids—$4,600—creates both opportunity and scrutiny. A focused look at what happens when PE meets audiology. #PrivateEquity #HearingAids #HealthcareInvesting #RollUp #Audibel #HearingLife #OTCHeaingAids #Demographics #Consolidation #BusinessAcquisition #HealthcareRollUp #FexingoBusiness #BusinessPodcast #TheBuyoutShow #Audiology #SilverEconomy #HealthcarePE #MergerAndAcquisition Keep every episode free: buymeacoffee.com/fexingo

Episode metadata supplied by the publisher feed · Published Jul 5, 2026

Embed this episode

Attribution link and audio player

NOW PLAYING

Why Private Equity Is Buying Up Hearing Aid Dispensaries

0:00 10:45

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The Buyout Show with Fexingo: Private Equity, Roll-Ups, and Business Acquisitions?

This episode is 10 minutes long.

When was this The Buyout Show with Fexingo: Private Equity, Roll-Ups, and Business Acquisitions episode published?

This episode was published on July 5, 2026.

Can I download this The Buyout Show with Fexingo: Private Equity, Roll-Ups, and Business Acquisitions episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!